Bausch Health Companies Statistics
Total Valuation
BHC has a market cap or net worth of $2.57 billion. The enterprise value is $22.30 billion.
| Market Cap | 2.57B |
| Enterprise Value | 22.30B |
Important Dates
The last earnings date was Wednesday, October 29, 2025, after market close.
| Earnings Date | Oct 29, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
BHC has 370.52 million shares outstanding. The number of shares has increased by 1.50% in one year.
| Current Share Class | 370.52M |
| Shares Outstanding | 370.52M |
| Shares Change (YoY) | +1.50% |
| Shares Change (QoQ) | +0.64% |
| Owned by Insiders (%) | 10.56% |
| Owned by Institutions (%) | 37.36% |
| Float | 223.27M |
Valuation Ratios
The trailing PE ratio is 7.17 and the forward PE ratio is 1.67.
| PE Ratio | 7.17 |
| Forward PE | 1.67 |
| PS Ratio | 0.26 |
| Forward PS | 0.24 |
| PB Ratio | 7.21 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 2.34 |
| P/OCF Ratio | 1.70 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 6.79, with an EV/FCF ratio of 20.37.
| EV / Earnings | 61.61 |
| EV / Sales | 2.22 |
| EV / EBITDA | 6.79 |
| EV / EBIT | 10.82 |
| EV / FCF | 20.37 |
Financial Position
The company has a current ratio of 1.30, with a Debt / Equity ratio of 59.11.
| Current Ratio | 1.30 |
| Quick Ratio | 0.78 |
| Debt / Equity | 59.11 |
| Debt / EBITDA | 6.22 |
| Debt / FCF | 19.22 |
| Interest Coverage | 1.33 |
Financial Efficiency
Return on equity (ROE) is 563.16% and return on invested capital (ROIC) is 6.04%.
| Return on Equity (ROE) | 563.16% |
| Return on Assets (ROA) | 4.83% |
| Return on Invested Capital (ROIC) | 6.04% |
| Return on Capital Employed (ROCE) | 9.36% |
| Revenue Per Employee | $484,493 |
| Profits Per Employee | $17,488 |
| Employee Count | 20,700 |
| Asset Turnover | 0.38 |
| Inventory Turnover | 1.81 |
Taxes
In the past 12 months, BHC has paid $199.00 million in taxes.
| Income Tax | 199.00M |
| Effective Tax Rate | 38.27% |
Stock Price Statistics
The stock price has decreased by -14.76% in the last 52 weeks. The beta is 0.41, so BHC's price volatility has been lower than the market average.
| Beta (5Y) | 0.41 |
| 52-Week Price Change | -14.76% |
| 50-Day Moving Average | 6.44 |
| 200-Day Moving Average | 6.25 |
| Relative Strength Index (RSI) | 56.44 |
| Average Volume (20 Days) | 3,065,352 |
Short Selling Information
The latest short interest is 6.66 million, so 1.80% of the outstanding shares have been sold short.
| Short Interest | 6.66M |
| Short Previous Month | 7.46M |
| Short % of Shares Out | 1.80% |
| Short % of Float | 2.98% |
| Short Ratio (days to cover) | 2.54 |
Income Statement
In the last 12 months, BHC had revenue of $10.03 billion and earned $362.00 million in profits. Earnings per share was $0.97.
| Revenue | 10.03B |
| Gross Profit | 7.09B |
| Operating Income | 2.06B |
| Pretax Income | 520.00M |
| Net Income | 362.00M |
| EBITDA | 3.29B |
| EBIT | 2.06B |
| Earnings Per Share (EPS) | $0.97 |
Balance Sheet
The company has $1.31 billion in cash and $21.04 billion in debt, giving a net cash position of -$19.73 billion or -$53.26 per share.
| Cash & Cash Equivalents | 1.31B |
| Total Debt | 21.04B |
| Net Cash | -19.73B |
| Net Cash Per Share | -$53.26 |
| Equity (Book Value) | 356.00M |
| Book Value Per Share | -1.53 |
| Working Capital | 1.46B |
Cash Flow
In the last 12 months, operating cash flow was $1.51 billion and capital expenditures -$411.00 million, giving a free cash flow of $1.10 billion.
| Operating Cash Flow | 1.51B |
| Capital Expenditures | -411.00M |
| Free Cash Flow | 1.10B |
| FCF Per Share | $2.96 |
Margins
Gross margin is 70.67%, with operating and profit margins of 20.55% and 3.61%.
| Gross Margin | 70.67% |
| Operating Margin | 20.55% |
| Pretax Margin | 5.18% |
| Profit Margin | 3.61% |
| EBITDA Margin | 32.76% |
| EBIT Margin | 20.55% |
| FCF Margin | 10.92% |
Dividends & Yields
BHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.50% |
| Shareholder Yield | n/a |
| Earnings Yield | 14.10% |
| FCF Yield | 42.65% |
Analyst Forecast
The average price target for BHC is $9.00, which is 29.87% higher than the current price. The consensus rating is "Hold".
| Price Target | $9.00 |
| Price Target Difference | 29.87% |
| Analyst Consensus | Hold |
| Analyst Count | 2 |
| Revenue Growth Forecast (5Y) | 0.07% |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on October 5, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Oct 5, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
BHC has an Altman Z-Score of 0.25 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.25 |
| Piotroski F-Score | 7 |